New York, New York, United States JDRF (The Juvenile Diabetes Research Foundation) is the famous Corporate Investor, which was founded in 1970. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the New York.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Gamification, Genetics. The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight AnTolRx, TidePool, Frequency Therapeutics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The real fund results show that this Corporate Investor is 5 percentage points more often commits exit comparing to other companies. This JDRF (The Juvenile Diabetes Research Foundation) works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars.
The fund was created by Carol Lurie.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the JDRF (The Juvenile Diabetes Research Foundation), startups are often financed by Tim Draper, Sanderling Ventures, Morningside Group. The meaningful sponsors for the fund in investment in the same round are W.L. Gore & Associates, The Leona M. and Harry B. Helmsley Charitable Trust, Pfizer Venture Investments. In the next rounds fund is usually obtained by Taiwania Capital, Cobro Ventures, W.L. Gore & Associates.
| Fund Name | Location |
| Beijing Yanhuang | Beijing, China, Fangshan |
| Candy Ventures | Luxembourg, Luxembourg |
| CBS Radio | New York, New York, United States |
| Charles Hood Foundation | Boston, Massachusetts, United States |
| Estrella Roja | - |
| Hadean Ventures | Norway, Oslo |
| Invariantes Fund | Guatemala, Guatemala City |
| Jiading Venture Capital | - |
| Jiuqi Keji | Beijing, China, Haidian |
| JPIN | England, London, United Kingdom |
| Maeda | Japan, Tokyo |
| Momentum Equity Partners | Boston, Massachusetts, United States |
| NewSpring Ventures | Pennsylvania, Radnor, United States |
| Nolabey Grup | - |
| Nordic Consumer Health | Nacka, Stockholms Lan, Sweden |
| Ocean Road Partners | California, United States, Venice |
| Primitive Ventures | California, San Francisco, United States |
| Shuangliang Group | - |
| Soldier Venture | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AnTolRx | $4M | 08 Sep 2016 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AnTolRx | $4M | 08 Sep 2016 | Cambridge, Massachusetts, United States |
